A patient bled green, surprising surgeons. Something from Star Trek? No, simply high doses of Imitrex. Who knew?
The patient had been taking large doses of sumatriptan – 200 milligrams a day.
This had caused a rare condition called sulfhaemoglobinaemia, where sulphur is incorporated into the oxygen-carrying compound haemoglobin in red blood cells.
Describing the case in The Lancet, the doctors led by Dr Alana Flexman from St Paul’s Hospital in Vancouver wrote: “The patient recovered uneventfully, and stopped taking sumatriptan after discharge.
“When seen five weeks after his last dose, he was found to have no sulfhaemoglobin in his blood.”






![Medical brain drain leaves vulnerable communities without life-saving care [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)
![Catching type 1 diabetes before it becomes life-threatening [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)

![Regulatory red tape threatens survival of rare disease patients [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)

